The Latest Breaking News from Medicare

The gun violence bill nearing congressional approval is wide-ranging but chiefly makes modest changes in existing programs

A Senate deal to cap the cost of insulin at $35 a month for individuals with private insurance and Medicare poses a new test of whether Democrats can make good on campaign pledges to rein in drug costs, Axios' Adriel Bettelheim writes.

WASHINGTON — Two key senators on Wednesday released a widely anticipated bill aimed at lowering insulin prices and capping monthly copays under commercial and Medicare insurance plans.

The bill would cap insulin copays at the lesser of $35 or 25 percent of the list price per month in commercial and Medicare Part D plans.

TPG Capital, private equity, has agreed to acquire Convey Health Solutions Holdings Inc (NYSE:CNVY) for $10.50 per share in cash, representing an enterprise value of approximately $1.1 billion. The purchase price represents approximately 99% over Convey's 30-day volume-weighted average price per share as of June 17 and a premium of approximately 143% to…

The Supreme Court decides in favor of an insurer in a case focused on reimbursement rates for kidney dialysis.

The federal government is undervaluing general practices around the country, according to a doctor who says cost pressures are pushing patients to hospital emergency departments.

Sometimes good news comes with a cloudy lining.

MEXICO, Missouri — When the new corporate owners of two rural hospitals suddenly announced they would stop admitting patients one Friday in March, Kayla Schudel, a nurse, stood resolute in the nearly empty lobby of Audrain Community Hospital: “You’ll be seen; the ER is open.”